ミネソタ州における間質性肺疾患の臨床試験
ミネソタ州内の拠点で、間質性肺疾患に関する14件の研究が参加者を募集しています。
ミネソタ州内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Minnesota, Minneapolis
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/30更新 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Minnesota, Minneapolis
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/29更新 · NCT05798923Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Minnesota, Minneapolis
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Mayo Clinic - Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Mayo Clinic, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
被験者募集中第2/3相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Minnesota, Minneapolis
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Mayo Clinic, Rochester
被験者募集中第2相
4歳以上 · 全性別 · 2026/07/22更新 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Minnesota Health Clinical Research Unit (CRU), Minneapolis
- Mayo Clinic, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of Minnesota, Minneapolis
被験者募集中観察研究
24歳以下 · 全性別 · 2026/06/22更新 · NCT04098445Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- Mayo Clinic, Rochester
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/29更新 · NCT03478826Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- University of Minnesota, Minneapolis
- Mayo Clinic in Rochester, Rochester
被験者募集中
18歳以上 · 全性別 · 2026/03/20更新 · NCT06751069Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/01/21更新 · NCT05120934ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。